Abstract Purpose of the Review Esophageal cancer is the sixth most common cause of
cancer death globally. Squamous cell carcinoma of the esophagus (ESCC) is the …

Surgery is the oldest oncological discipline, dating back thousands of years. Prior to the
advent of anaesthesia and antisepsis 150 years ago, only the brave, desperate, or ill …

Background After neoadjuvant chemoradiotherapy for oesophageal cancer, roughly half of
the patients with squamous cell carcinoma and a quarter of those with adenocarcinoma …

Background Neoadjuvant chemoradiotherapy (nCRT) plus surgery is a standard treatment
for locally advanced oesophageal cancer. With this treatment, 29% of patients have a …

Survival of esophageal cancer is improving but remains poor. Esophageal cancer stage is
based on depth of tumor invasion, involvement of regional lymph nodes, and the presence …

Objective: The aim of this study was to perform a meta-analysis on the accuracy of
endoscopic biopsies, EUS, and 18F-FDG PET (-CT) for detecting residual disease after …

Objective: This study compared outcomes of patients with esophageal cancer and clinically
complete response (cCR) after neoadjuvant chemoradiotherapy (nCRT) undergoing active …

Leakage from the esophagus and gastroesophageal junction can be lethal due to
uncontrolled contamination of the mediastinum. The most predominant risk factors for the …

Objective: To compare overall survival of patients with a cCR undergoing active surveillance
versus standard esophagectomy. Summary of Background Data: One-third of patients with …

Esophageal squamous cell carcinoma (ESCC) is a common malignancy worldwide and
often diagnosed at advanced stages with poor prognosis. Combination of radiotherapy and …